Editorial Disclosure: GLP-1 Editorial is an editorial publication operated by Ranika Editorial Group LLC. We do not provide medical care, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Our rankings are based on our published v3.0 transparency rubric, publicly available provider information, cited sources, and periodic review updates. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page and at /affiliate-disclosure.html.
Last reviewed: May 31, 2026
Next scheduled review: June 30, 2026
Reviewed by: Dr. Sam Saberian, Lead Medical Researcher
Edited by: Julliana Edwards, Editor
Methodology: GLP-1 Editorial v3.0 rubric
Sexual Health · Provider Directory · Updated 2026-05-11

Sexual Health Peptides & Therapies

Sexual health peptides target melanocortin (PT-141 / bremelanotide) and oxytocin pathways for desire and arousal disorders, and GnRH-receptor agonism (gonadorelin, kisspeptin) for endogenous hormone modulation. PT-141 is FDA-approved as Vyleesi for HSDD in premenopausal women; the rest are off-label or compounded.

5 peptides covered v3.0 rubric Updated 2026-05-11 Availability varies by state + DC
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-05-11

Peptides in this category

Sexual Health
PT-141
Bremelanotide, Vyleesi
 Sexual Health
Oxytocin
Bonding, arousal
 Sexual Health
Kisspeptin
KISS1, hypothalamic
 Sexual Health
Gonadorelin
GnRH, Factrel
 Sexual Health
Melanotan II
MT-II, melanocortin

Top telehealth providers for sexual health

See the full provider directory for complete profiles, pricing, and v3.0 transparency scoring.

Editorial team

Reviews authored by Dr. Sam Saberian (Lead Medical Researcher), medically reviewed by Alen A. Schwartz, MD, and edited by Julliana Edwards (Editor). About our team →

Related categories

Important medical and regulatory disclosure: Compounded semaglutide and compounded tirzepatide are not FDA-approved. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Editorial does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.